AVEO: LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial

LG Chem and AVEO Oncology announced the enrolment of the first subject in Phase I study of LB-LR1109, an anti-cancer investigational drug. The post LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial appeared first on Clinical Trials Arena.